Request the Commissioner of Food and Drugs to take urgent action concerning the off-label use of GnRH agonists, a class of drugs also known as Puberty Blockers in Children. | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2023-P-3767

Request the Commissioner of Food and Drugs to take urgent action concerning the off-label use of GnRH agonists, a class of drugs also known as Puberty Blockers in Children.

Documents

Comments

726

Description

Open

Key Dates

Comment Period OpensSep 5, 2023

Documents

Type	Title	Posted	Comments	Status
Other	Addendum to Supplement filed on April 15, 2024 from Nancy Stade et al.	May 14, 2024	--

Comment Statistics

Total Comments

726

Keywords

CDER

Citizen Petition

take urgent action concerning the off-label

use of GnRH agonists, a class of drugs also

known as Puberty Blockers in Children.

Create a dedicated web page concerning

this off-label use

Alert manufacturers and providers

Data from Regulations.gov